Alamar Biosciences Inc.
ALMR | NASDAQ
$28.89
-$1.71 (-5.59%)
Nov 2, 2026, 3:43 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
PE Ratio | -51.11 | -70.97 | n/a | n/a |
PEG Ratio | 1.76 | n/a | n/a | n/a |
PS Ratio | 28.65 | 58.57 | n/a | n/a |
PB Ratio | 5.08 | -8.56 | n/a | n/a |
P/FCF Ratio | -44.25 | -72.80 | n/a | n/a |
P/OCF Ratio | -50.18 | -74.94 | n/a | n/a |
OCF/S Ratio | -38.47 | -78.15 | n/a | n/a |
Debt / Equity Ratio | 0.16 | -1.91 | -0.26 | n/a |
Quick Ratio | 10.23 | 4.02 | 2.37 | n/a |
Current Ratio | 11.85 | 5.68 | 3.99 | n/a |
Asset Turnover | 0.08 | 0.14 | n/a | n/a |
Interest Coverage | -60.41 | -55.37 | n/a | n/a |
Return on Equity | -4.22% | 11.98% | n/a | n/a |
Return on Assets | -3.38% | -11.44% | n/a | n/a |
Return on Invested Capital | -3.68% | -7.53% | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | 60.21% | 55.53% | n/a | n/a |
Net Profit Margin | -44.85% | -81.91% | n/a | n/a |
Pretax Profit Margin | -45.17% | -80.13% | n/a | n/a |
Operating Profit Margin | -45.98% | -47.42% | n/a | n/a |
FCF Margin | -50.85% | -80.46% | n/a | n/a |
EBITDA Margin | -44.41% | -74.79% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ALMR